Attached files

file filename
EX-99.2 - FORM OF COMPENSATION COMMITTEE CHARTER - Larkspur Health Acquisition Corp.fs12021a4ex99-2_larkspur.htm
EX-99.1 - FORM OF AUDIT COMMITTEE CHARTER - Larkspur Health Acquisition Corp.fs12021a4ex99-1_larkspur.htm
EX-23.1 - CONSENT OF MARCUM LLP - Larkspur Health Acquisition Corp.fs12021a4ex23-1_larkspur.htm
EX-14 - FORM OF CODE OF ETHICS - Larkspur Health Acquisition Corp.fs12021a4ex14_larkspur.htm
EX-10.17 - SIDE LETTER, DATED SEPTEMBER 11, 2021, BETWEEN THE REGISTRANT AND A.G.P./ALLIANC - Larkspur Health Acquisition Corp.fs12021a4ex10-17_larkspur.htm
EX-10.16 - FORM OF INDEMNITY AGREEMENT - Larkspur Health Acquisition Corp.fs12021a4ex10-16_larkspur.htm
EX-10.15 - FORM OF PRIVATE UNITS PURCHASE AGREEMENT BETWEEN THE REGISTRANT AND LARKSPUR HEA - Larkspur Health Acquisition Corp.fs12021a4ex10-15_larkspur.htm
EX-10.14 - SUBSCRIPTION AGREEMENT, DATED MAY 7, BETWEEN THE REGISTRANT AND CHRISTOPHER TWIT - Larkspur Health Acquisition Corp.fs12021a4ex10-14_larkspur.htm
EX-10.13 - SUBSCRIPTION AGREEMENT, DATED MAY 7, BETWEEN THE REGISTRANT AND GREGORY SKALICKY - Larkspur Health Acquisition Corp.fs12021a4ex10-13_larkspur.htm
EX-10.12 - SUBSCRIPTION AGREEMENT, DATED MAY 7, BETWEEN THE REGISTRANT AND RAJ MEHRA, PH.D. - Larkspur Health Acquisition Corp.fs12021a4ex10-12_larkspur.htm
EX-10.11 - SUBSCRIPTION AGREEMENT, DATED MAY 7, BETWEEN THE REGISTRANT AND A.G.P./ALLIANCE - Larkspur Health Acquisition Corp.fs12021a4ex10-11_larkspur.htm
EX-10.10 - SUBSCRIPTION AGREEMENT, DATED MAY 7, BETWEEN THE REGISTRANT AND LARKSPUR HEALTH - Larkspur Health Acquisition Corp.fs12021a4ex10-10_larkspur.htm
EX-10.9 - FORM OF REGISTRATION RIGHTS AGREEMENT BETWEEN THE REGISTRANT AND CERTAIN SECURIT - Larkspur Health Acquisition Corp.fs12021a4ex10-9_larkspur.htm
EX-10.8 - FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER - Larkspur Health Acquisition Corp.fs12021a4ex10-8_larkspur.htm
EX-10.7 - PROMISSORY NOTE, DATED MAY 7, 2021, ISSUED TO JEFFRY BERNSTEIN - Larkspur Health Acquisition Corp.fs12021a4ex10-7_larkspur.htm
EX-10.6 - PROMISSORY NOTE, DATED MAY 7, 2021, ISSUED TO MITCHELL SCHIFF - Larkspur Health Acquisition Corp.fs12021a4ex10-6_larkspur.htm
EX-10.5 - PROMISSORY NOTE, DATED MAY 7, 2021, ISSUED TO S.H.N. FINANCIAL INVESTMENTS LTD. - Larkspur Health Acquisition Corp.fs12021a4ex10-5_larkspur.htm
EX-10.4 - PROMISSORY NOTE, DATED MAY 7, 2021, ISSUED TO DANIEL J. O'CONNOR - Larkspur Health Acquisition Corp.fs12021a4ex10-4_larkspur.htm
EX-10.3 - PROMISSORY NOTE, DATED MAY 7, 2021, ISSUED TO L1 CAPITAL GLOBAL OPPORTUNITIES MA - Larkspur Health Acquisition Corp.fs12021a4ex10-3_larkspur.htm
EX-10.2 - PROMISSORY NOTE, DATED MAY 7, 2021, ISSUED TO LAKESPUR HOLDINGS LLC - Larkspur Health Acquisition Corp.fs12021a4ex10-2_larkspur.htm
EX-10.1 - FORM OF LETTER AGREEMENT AMONG THE REGISTRANT AND OUR OFFICERS, DIRECTORS AND LA - Larkspur Health Acquisition Corp.fs12021a4ex10-1_larkspur.htm
EX-5.1 - OPINION OF MCDERMOTT WILL & EMERY LLP - Larkspur Health Acquisition Corp.fs12021a4ex5-1_larkspur.htm
EX-4.3 - SPECIMEN WARRANT CERTIFICATE - Larkspur Health Acquisition Corp.fs12021a4ex4-3_larkspur.htm
EX-4.2 - SPECIMEN CLASS A COMMON STOCK CERTIFICATE - Larkspur Health Acquisition Corp.fs12021a4ex4-2_larkspur.htm
EX-4.1 - SPECIMEN UNIT CERTIFICATE - Larkspur Health Acquisition Corp.fs12021a4ex4-1_larkspur.htm
EX-3.3 - AMENDED AND RESTATED BYLAWS - Larkspur Health Acquisition Corp.fs12021a4ex3-3_larkspur.htm
EX-3.2 - AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - Larkspur Health Acquisition Corp.fs12021a4ex3-2_larkspur.htm
EX-1.2 - BUSINESS COMBINATION AGREEMENT - Larkspur Health Acquisition Corp.fs12021a4ex1-2_larkspur.htm
EX-1.1 - FORM OF UNDERWRITING AGREEMENT - Larkspur Health Acquisition Corp.fs12021a4ex1-1_larkspur.htm
S-1/A - REGISTRATION STATEMENT - Larkspur Health Acquisition Corp.fs12021a4_larkspurhealthacq.htm

Exhibit 3.1

 

State of Delaware  
Secretary of State  
Division of Corporations  
Delivered 04:23 PM 03/17/2021  
FILED 04:23 PM 03/17/2021  
SR 20210944917 - File Number 5547135  

 

CERTIFICATE OF INCORPORATION

OF

Larkspur Health Acquisition Corp.

 

The undersigned, for the purpose of organizing a corporation for conducting the business and promoting the purposes hereinafter stated, under the provisions and subject to the requirements of the laws of the State of Delaware (particularly Chapter 1, Title 8 of the Delaware Code and the acts amendatory thereof and supplemental thereto, and known, identified, and referred to as the “General Corporation Law of the State of Delaware”), hereby certifies that:

 

FIRST: The name of the corporation is Larkspur Health Acquisition Corp. (hereinafter called the “Corporation”).

 

SECOND: The address, including street, number, city, and county, of the registered office of the Corporation in the State of Delaware is 1013 Centre Road, Suite 403-B, Wilmington, Delaware 19805, in the County of New Castle; and the name of the registered agent of the corporation in the State of Delaware at such address is Vcorp Services, LLC.

 

THIRD: The nature of the business and the purposes to be conducted and promoted by the Corporation are as follows:

 

To conduct any lawful business, to promote any lawful purpose, and to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware.

 

FOURTH: Authorized Capital Stock The total number of shares of all classes of capital stock, each with a par value of $0.0001 per share, which the Corporation is authorized to issue is 221,000,000 shares, consisting of (a) 220,000,000 shares of common stock (the “Common Stock”), including (i) 200,000,000 shares of Class A common stock (the “Class A Common Stock”), and (ii) 20,000,000 shares of Class B common stock (the “Class B Common Stock”), and (b) 1,000,000 shares of preferred stock (the “Preferred Stock”).

 

Preferred Stock:

 

The board of directors of the Corporation (the “Board”) is hereby expressly authorized to provide, out of the unissued shares of the Preferred Stock, one or more series of Preferred Stock, and to establish from time to time the number of shares to be included in each such series and to fix the voting rights, if any, designations, powers, preferences and relative, participating, optional, special and other rights, if any, of each such series and any qualifications, limitations and restrictions thereof, as shall be stated in the resolution or resolutions adopted by the Board providing for the issuance of such series and included in a certificate of designation (a “Preferred Stock Designation”) filed pursuant to the DGCL, and the Board is hereby expressly vested with the authority to the full extent provided by law, now or hereafter, to adopt any such resolution or resolutions.

 

1

 

 

Common Stock:

 

(a) Voting

 

(i) Except as otherwise required by law or this Certificate (including any Preferred Stock Designation), the holders of the Common Stock shall exclusively possess all voting power with respect to the Corporation.

 

(ii) Except as otherwise required by law or this Certificate (including any Preferred Stock Designation), the holders of shares of Common Stock shall be entitled to one vote for each such share on each matter properly submitted to the stockholders on which the holders of the Common Stock are entitled to vote.

 

(iii) Except as otherwise required by law or this Certificate (including any Preferred Stock Designation), at any annual or special meeting of the stockholders of the Corporation, holders of the Class A Common Stock and holders of the Class B Common Stock, voting together as a single class, shall have the exclusive right to vote for the election of directors and on all other matters properly submitted to a vote of the stockholders. Notwithstanding the foregoing, except as otherwise required by law or this Certificate (including any Preferred Stock Designation), holders of shares of any series of Common Stock shall not be entitled to vote on any amendment to this Certificate (including any amendment to any Preferred Stock Designation) that relates solely to the terms of one or more outstanding series of Preferred Stock or other series of Common Stock if the holders of such affected series of Preferred Stock or Common Stock, as applicable, are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to this Certificate (including any Preferred Stock Designation) or the DGCL.

 

(b) Class B Common Stock

 

(i) Shares of Class B Common Stock shall be convertible into shares of Class A Common Stock on a one-for-one basis (the “Initial Conversion Ratio”) (A) at any time and from time to time at the option of the holder thereof and (B) automatically upon the consummation of the Business Combination (as defined below).

 

2

 

 

(ii) Notwithstanding the Initial Conversion Ratio, in the case that additional shares of Class A Common Stock, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Corporation’s initial public offering of securities and related to the closing of the initial Business Combination, all issued and outstanding shares of Class B Common Stock shall automatically convert into shares of Class A Common Stock at the time of the closing of the Corporation’s initial merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”) at a ratio for which:

 

the numerator shall be equal to the sum of (A) 25% of all shares of Class A Common Stock issued or issuable (upon the conversion or exercise of any equity-linked securities or otherwise) by the Corporation, related to or in connection with the consummation of the initial Business Combination (excluding any securities issued or issuable to any seller in the initial Business Combination) plus (B) the number of shares of Class B Common Stock issued and outstanding prior to the closing of the initial Business Combination; and

 

the denominator shall be the number of shares of Class B Common Stock issued and outstanding prior to the closing of the initial Business Combination.

 

Notwithstanding anything to the contrary contained herein, (i) the foregoing adjustment to the Initial Conversion Ratio may be waived as to any particular issuance or deemed issuance of additional shares of Class A Common Stock or equity-linked securities by the written consent or agreement of holders of a majority of the shares of Class B Common Stock then outstanding consenting or agreeing separately as a single class in the manner provided in Section 4.3(b)(iii), and (ii) in no event shall the Class B Common Stock convert into Class A Common Stock at a ratio that is less than one-for-one.

 

The foregoing conversion ratio shall also be adjusted to account for any subdivision (by stock split, subdivision, exchange, stock dividend, reclassification, recapitalization or otherwise) or combination (by reverse stock split, exchange, reclassification, recapitalization or otherwise) or similar reclassification or recapitalization of the outstanding shares of Class A Common Stock into a greater or lesser number of shares occurring after the original filing of this Certificate without a proportionate and corresponding subdivision, combination or similar reclassification or recapitalization of the outstanding shares of Class B Common Stock.

 

Each share of Class B Common Stock shall convert into its pro rata number of shares of Class A Common Stock pursuant to this Section 4.3(b). The pro rata share for each holder of Class B Common Stock will be determined as follows: Each share of Class B Common Stock shall convert into such number of shares of Class A Common Stock as is equal to the product of one (1) multiplied by a fraction, the numerator of which shall be the total number of shares of Class A Common Stock into which all of the issued and outstanding shares of Class B Common Stock shall be converted pursuant to this Section 4.3(b) and the denominator of which shall be the total number of issued and outstanding shares of Class B Common Stock at the time of conversion.

 

3

 

 

(iii) Voting. Except as otherwise required by law or this Certificate (including any Preferred Stock Designation), for so long as any shares of Class B Common Stock shall remain outstanding, the Corporation shall not, without the prior vote or written consent of the holders of a majority of the shares of Class B Common Stock then outstanding, voting separately as a single class, amend, alter or repeal any provision of this Certificate, whether by merger, consolidation or otherwise, if such amendment, alteration or repeal would alter or change the powers, preferences or relative, participating, optional or other or special rights of the Class B Common Stock. Any action required or permitted to be taken at any meeting of the holders of Class B Common Stock may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken, shall be signed by the holders of the outstanding Class B Common Stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares of Class B Common Stock were present and voted and shall be delivered to the Corporation by delivery to its registered office in the State of Delaware, its principal place of business, or an officer or agent of the Corporation having custody of the book in which minutes of proceedings of stockholders are recorded. Delivery made to the Corporation’s registered office shall be by hand or by certified or registered mail, return receipt requested. Prompt written notice of the taking of corporate action without a meeting by less than unanimous written consent of the holders of Class B Common Stock shall, to the extent required by law, be given to those holders of Class B Common Stock who have not consented in writing and who, if the action had been taken at a meeting, would have been entitled to notice of the meeting if the record date for notice of such meeting had been the date that written consents signed by a sufficient number of holders of Class B Common Stock to take the action were delivered to the Corporation.

 

(c) Dividends

 

Subject to applicable law, the rights, if any, of the holders of any outstanding series of the Preferred Stock, the holders of shares of Common Stock shall be entitled to receive such dividends and other distributions (payable in cash, property or capital stock of the Corporation) when, as and if declared thereon by the Board from time to time out of any assets or funds of the Corporation legally available therefor and shall share equally on a per share basis in such dividends and distributions.

 

4

 

 

(d) Liquidation

 

Dissolution or Winding Up of the Corporation. Subject to applicable law, the rights, if any, of the holders of any outstanding series of the Preferred Stock, in the event of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, after payment or provision for payment of the debts and other liabilities of the Corporation, the holders of shares of Common Stock shall be entitled to receive all the remaining assets of the Corporation available for distribution to its stockholders, ratably in proportion to the number of shares of Class A Common Stock (on an as converted basis with respect to the Class B Common Stock) held by them.

 

Rights and Options

 

The Corporation has the authority to create and issue rights, warrants and options entitling the holders thereof to acquire from the Corporation any shares of its capital stock of any class or classes, with such rights, warrants and options to be evidenced by or in instrument(s) approved by the Board. The Board is empowered to set the exercise price, duration, times for exercise and other terms and conditions of such rights, warrants or options; provided, however, that the consideration to be received for any shares of capital stock issuable upon exercise thereof may not be less than the par value thereof.

 

FIFTH: The name and the mailing address of the incorporator are as follows:

 

NAME MAILING ADDRESS
   
William Zayac

25 Robert Pitt Drive, Suite 204

Monsey,

New York 10952

 

SIXTH: The Board of Directors shall have the power to adopt, amend or repeal the by-laws of the Corporation.

 

SEVENTH: The Corporation shall have perpetual existence.

 

EIGHTH: The personal liability of the directors of the corporation is hereby eliminated to the fullest extent permitted by the provisions of paragraph (7) of subsection (b) of Section 102 of the General Corporation Law of the State of Delaware, as the same may be amended and supplemented. Notwithstanding the foregoing sentence, a director shall be liable to the extent provided by applicable law, (i) for breach of the director’s duty of loyalty to the Corporation, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) pursuant to Section 174 of the General Corporation Law of the State of Delaware or (iv) for any transaction from which the director derived an improper personal benefit. No amendment to or repeal of this Article Eighth shall apply to or have any effect on the liability or alleged liability of any director of the Corporation for or with respect to any acts or omissions of such director occurring prior to such amendment.

 

NINTH: The corporation shall, to the fullest extent permitted by the provisions of Section 145 of the General Corporation Law of the State of Delaware, as the same may be amended and supplemented, indemnify any and all persons whom it shall have power to indemnify under said section from and against any and all of the expenses, liabilities, or other matters referred to in or covered by said section, and the indemnification provided for herein shall not be deemed exclusive of any other rights to which those indemnified may be entitled under any Bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person’s official capacity and as to action in another capacity while holding such office, and shall continue as to a person who has ceased to be a director, officer, employee, or agent and shall inure to the benefit of the heirs, executors, and administrators of such person.

 

5

 

 

IN WITNESS WHEREOF, the undersigned, being the incorporator herein before named, has executed and acknowledged this Certificate of Incorporation.

 

Date: March 17, 2021

 

  /s/ William Zayac
  William Zayac
  Incorporator

 

 

6